NCT01524640View on ClinicalTrials.gov

Bridging Study for Killed Oral Cholera Vaccine in Ethiopia

PHASE4CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Vibrio CholeraeCholera
Interventions
BIOLOGICAL

Killed Bivalent (O1 and O139) whole cell oral cholera vaccine

1.5 ml single dose oral administration on day 0 and day 14

BIOLOGICAL

Placebo

1.5 ml oral administration on day 0 and day 14

Trial Locations (1)

Unknown

Armauer Hansen Research Institute, Addis Ababa

All Listed Sponsors
collaborator

Armauer Hansen Research Institute, Ethiopia

OTHER

collaborator

Ministry of Health, Ethiopia

OTHER_GOV

collaborator

Shantha Biotechnics Limited

INDUSTRY

lead

International Vaccine Institute

OTHER

NCT01524640 - Bridging Study for Killed Oral Cholera Vaccine in Ethiopia | Biotech Hunter | Biotech Hunter